Kalliopi Stasi, Novartis (E);
Vance Thompson, Acufocus, Alcon, Allergan, Allotex, Avellino, Avisi Technologies, Inc, Bausch and Lomb, BRIM Biotechnology, Inc, Carl Zeiss Meditec, Conjtac, CSO, Equinox, Euclid Systems, Expert Opinion, eyeBrain Medical Inc, Eyedetec, EyeGate Pharma, Forsight Robotics, Glaukos, Healthe, Imprimis, iVeena, Johnson and Johnson, Leica, Melt Pharmaceuticals, Mynosys, Novaliq, Ocular Innovations, OneFocus, OPHTEC, ORA, Oyster Point Pharma, Percept, Precision Lens, ReFocus, RxSight, SightSciences, Stuart Therapeutics, Tarsus Rx, TearClear, TherOptix, ThruFocus, Treehouse Health, Veracity, Viewpoint Therapeutics, Visant, Visiometrics, Vivior AG. (C), Acufocus, Alcon, Allergan, Bausch and Lomb, Carl Zeiss Meditec, Equinox, EyeGate Pharma, Glaukos, Johnson and Johnson, and ORA, RxSight, and SightSciences (F), Acufocus, Alcon, Glaukos, and Johnson and Johnson (R), Acufocus, Allotex, Avellino, Conjtac, Euclid Systems, Equinox, EyeGate Pharma, Expert Opinion, eyeBrain Medical Inc, Eyedetec, Forsight Robotics, Healthe, iVeena, Melt Pharmaceuticals, Mynosys, Ocular Innovations, Oyster Point Pharma, Percept, RxSight, SightSciences, Stuart Therapeutics, Tarsus Rx, TearClear, TherOptix, Treehouse Health, Veracity, Visant, and Vivior AG (I);
Majid Moshirfar, None;
Thomas Clinch, Novartis (F);
Stephen Scoper, Alcon, Novartis (C);
Steven Linn, None;
Avery McIntosh, Novartis (E);
Yifang Li, Novartis (E);
Matt Eaton, Novartis (E);
Michela Montecchi Palmer, Novartis (E);
Sameena Haque, Novartis (E);
Michael Ferriere, Novartis (E)